Assignee
PHARMEXA INC
US·5 granted patents·5 pending applications·64 citations·filing 1993–2009
Top patents by PatentIndex Score
10 records- 0190US7462354B2Method and system for optimizing minigenes and peptides encoded therebyPHARMEXA INC·Filed 2001·Granted Dec 9, 2008·31 cites·20 claims
- 0284US7202351B1Alteration of immune response using pan DR-binding peptidesPHARMEXA INC·Filed 2000·Granted Apr 10, 2007·20 cites·14 claims
- 0383US7572882B2Inducing cellular immune responses to human papillomavirus using peptide and nucleic acid compositionsPHARMEXA INC·Filed 2000·Granted Aug 11, 2009·6 cites·13 claims
- 0472US7611713B2Inducing cellular immune responses to hepatitis B virus using peptide compositionsPHARMEXA INC·Filed 2003·Granted Nov 3, 2009·5 cites·5 claims
- 0565US2009214632A1Inducing cellular immune responses to human papillomavirus using peptide and nucleic acid compositionsPHARMEXA INC·Filed 2008·Application pending·0 cites
- 0659US2010068228A1Inducing Cellular Immune Responses to Hepatitis B Virus Using Peptide and Nucleic Acid CompositionsPHARMEXA INC·Filed 2009·Application pending·0 cites
- 0748US2011097352A9Inducing cellular immune responses to hepatitis B virus using peptide and nucleic acid compositionsPHARMEXA INC·Filed 2007·Application pending·0 cites
- 0846US2009304746A1Inducing cellar immune responses to hepatitis C virus using peptide and nucleic acid compositionsPHARMEXA INC·Filed 2007·Application pending·0 cites
- 0944US2007059799A1Inducing cellular immune responses to hepatitis B virus using peptide and nucleic acid compositionsPHARMEXA INC·Filed 2006·Application pending·0 cites
- 1034US7364741B1Peptides of human Papilloma virus for use in human T cell response inducing compositionsPHARMEXA INC·Filed 1993·Granted Apr 29, 2008·2 cites·12 claims
Join the waitlist — get patent alerts
Get an alert when PHARMEXA INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →